Cargando…

mRNA Vaccines for COVID-19: A Simple Explanation

Detalles Bibliográficos
Autores principales:	Hendaus, Mohamed A., Jomha, Fatima A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	HBKU Press 2021
Materias:	Commentary Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893482/ https://www.ncbi.nlm.nih.gov/pubmed/33643864 http://dx.doi.org/10.5339/qmj.2021.7

Ejemplares similares

Delta variant of COVID-19: A simple explanation
por: Hendaus, Mohamed A., et al.
Publicado: (2021)

Pulse oximetry in bronchiolitis: is it needed?
por: Hendaus, Mohamed A, et al.
Publicado: (2015)

Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel?
por: Hendaus, Mohamed A, et al.
Publicado: (2016)

Lung ultrasound for the diagnosis of childhood pneumonia: a safe and accurate imaging mode
por: Hendaus, Mohamed Ata, et al.
Publicado: (2015)

Uveitis following mRNA COVID-19 vaccination: Is it real?
por: Murugan, Sivaraman Bala, et al.
Publicado: (2023)

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies
por: Crombie, Jennifer L., et al.
Publicado: (2021)

Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study
por: Hatziantoniou, Sophia, et al.
Publicado: (2021)

Low-dose single-shot COVID-19 mRNA vaccines lie ahead
por: Sanders, Niek N.
Publicado: (2021)

mRNA vaccines: A matter of delivery
por: Cao, Yuhong, et al.
Publicado: (2021)

Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines
por: Kelso, John M.
Publicado: (2021)

The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism
por: Lazaros, George, et al.
Publicado: (2021)

Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
por: Bolze, Alexandre, et al.
Publicado: (2022)

Allergic diseases among children: nutritional prevention and intervention
por: Hendaus, Mohamed A, et al.
Publicado: (2016)

A Tolerizing mRNA Vaccine against Autoimmunity?
por: Furlan, Roberto
Publicado: (2021)

Virus-induced secondary bacterial infection: a concise review
por: Hendaus, Mohamed A, et al.
Publicado: (2015)

Is ketamine a lifesaving agent in childhood acute severe asthma?
por: Hendaus, Mohamed A, et al.
Publicado: (2016)

Understanding the variability of pharmaco‐epidemiological studies assessing the risk of appendicitis with mRNA COVID‐19 vaccines
por: Jambon‐Barbara, Clement, et al.
Publicado: (2022)

Vasopressin in the Amelioration of Social Functioning in Autism Spectrum Disorder
por: Hendaus, Mohamed A., et al.
Publicado: (2019)

mRNA, the beginning of a new influenza vaccine game
por: Pecetta, Simone, et al.
Publicado: (2022)

Debunking mRNA Vaccine Misconceptions—An Overview for Medical Professionals
por: Hitti, Frederick L., et al.
Publicado: (2021)

The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
por: Jhaveri, Ravi
Publicado: (2021)

COVID-19 mRNA vaccine safety, immunogenicity, and effectiveness in a hospital setting: confronting the challenge
por: Sultana, Janet, et al.
Publicado: (2022)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

Overcoming the challenge of long-term storage of mRNA-lipid nanoparticle vaccines
por: Young, Rachel E., et al.
Publicado: (2022)

Why Are Children With Bronchiolitis At Risk Of Urinary Tract Infections?
por: Hendaus, Mohamed A
Publicado: (2019)

A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer
por: Kang, Ning, et al.
Publicado: (2023)

COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021)

COVID-19 mRNA Vaccination
por: Vered, Livneh, et al.
Publicado: (2022)

Addressing the Cold Reality of mRNA Vaccine Stability
por: Crommelin, Daan J.A., et al.
Publicado: (2021)

Allergists Can Safely Evaluate and Revaccinate Individuals With Immediate Allergic Reactions to mRNA COVID-19 Vaccines
por: Greenhawt, Matthew, et al.
Publicado: (2021)

Cell fate conversion by mRNA
por: Li, Mo, et al.
Publicado: (2011)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations
por: Chaudhary, Rahul, et al.
Publicado: (2020)

Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California
por: Andrejko, Kristin L, et al.
Publicado: (2021)

What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
por: Silvestris, Nicola
Publicado: (2021)

Shingles and mRNA COVID‐19 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Commentary of the mRNA vaccines COVID-19
por: Vitiello, Antonio, et al.
Publicado: (2021)

COVID-19 mRNA Vaccine and Myocarditis
por: Singh, Balraj, et al.
Publicado: (2021)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID‐19 mRNA vaccines and myopericarditis
por: Gnanenthiran, Sonali R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_74j502tcd5hp8fpsjfrfn7utci